Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[2012: news in neurology].
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Erratum.
Risk of relapse phenotype recurrence in multiple sclerosis.
Glial Cell Development and Function in Zebrafish.
Imaging Phenotypes in Multiple Sclerosis.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
Statistical normalization techniques for magnetic resonance imaging.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Health beliefs and physical activity behavior in adults with multiple sclerosis.
Smokers run increased risk of developing anti-natalizumab antibodies.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
A web-based electronic neurology referral system: a solution for an overburdened healthcare system?
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Outer retinal changes following acute optic neuritis.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Does natalizumab therapy worsen neuromyelitis optica?
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »